NCT04042792View on ClinicalTrials.gov

Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

September 26, 2019

Primary Completion Date

June 28, 2021

Study Completion Date

June 28, 2021

Conditions
Rheumatic Diseases
Interventions
OTHER

pharmacokinetics (PK) measurement

two ADA-PK samples will be collected during routine rheumatology visits in case of medical indicated blood draw (1 trough PK sample and 1 random PK sample per subject)

Trial Locations (2)

4031

University of Basel Children's Hospital, Basel

72076

University Children's Hospital Tubingen, Tübingen

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04042792 - Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate | Biotech Hunter | Biotech Hunter